Written by Reuben Gregg Brewer for The Motley Fool -> Rare-earth metals are vital to the modern world, and demand is expected to be high. MP Materials has a …

Written by Leo Sun for The Motley Fool -> GE Vernova’s stock has skyrocketed since its public debut. The “AI grid supercycle” will drive its stock even highe…

Written by Brendan Coffey for The Motley Fool -> Intellia Therapeutics is leveraging its strategic partnership with Regeneron to advance a deep pipeline of CR…

Apple is permanently closing three stores in the United States later today. The company first announced the closures in April, impacting locations in Connectic…

CoinDesk's president of indices and data has a message for investors: Don't count out bitcoin. "When I got my first smartphone, which is a great example of a …

While it's not flashy like Apple’s new Siri AI and Apple Intelligence upgrades, there are still a number of additions to iOS 27 worth looking at.

The study compared three types of the medication: tirzepatide (better known under the brand names Zepbound and Mounjaro), semaglutide (sold as Wegovy and Ozemp…

The study compared three types of the medication: tirzepatide (better known under the brand names Zepbound and Mounjaro), semaglutide (sold as Wegovy and Ozemp…

How stock awards at OpenAI, Anthropic, and SpaceX grew into life-changing fortunes.

Written by Sean Williams for The Motley Fool -> Elon Musk's SpaceX cemented its place in the record books by raising $75 billion with its initial public offer…

Written by Lawrence Nga for The Motley Fool -> While Nvidia's AI-focused processors get all the attention, the company's software ecosystem could be an even m…